Procter & Gamble Health Posts 25.5% YoY Profit Jump in Q2

5 Nov 2024 , 10:23 PM

Procter & Gamble Health Ltd reported a 25.5% increase in net profit YoY for Q2 FY25, reaching ₹82.3 Crore, compared to ₹65.6 Crore in the same quarter last year.

At the time of closing on November 5, 2024 shares of Procter & Gamble Health Ltd closed at ₹5597 which is a 5.86% gain than the previous close. Procter & Gamble Health Ltd stock has gained a total of 9.82% in the last one year, and 12.71% gain since the beginning of the year.

The company’s revenue from operations grew 2.8% to ₹313.4 Crore, up from ₹304.9 Crore in Q2 FY24. At the operating level, EBITDA rose 28.7% YoY, totaling ₹114.1 Crore for the quarter, up from ₹88.7 Crore in Q2 FY24.

EBITDA margin expanded to 36.4% in Q2 FY25, a notable increase from 29.1% in the previous year’s quarter. Sales for Q2 FY25 showed a modest 3% YoY growth, amounting to ₹310 Crore. PAT (Profit After Tax), adjusted for a one-time impact in the previous period, rose 8% YoY.

Milind Thatte, Managing Director of P&G Health India, highlighted sequential growth and noted the company’s strategy, focusing on a quality-driven portfolio of trusted brands.

Emphasis on superiority across product quality, packaging, brand communication, and retail execution is central to P&G Health’s strategy, aimed at enhancing brand choice and performance.